Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,536,650
+$76,515 QoQ
Shares Held
7,005
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,145
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trek Financial, LLC holds $22,596,486 across 11 Drug Manufacturers - General names. AMGN ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
39,151 | $9,943,179 | |
| 2 | LLY |
ELI LILLY & Co
|
3,679 | $4,412,703 | |
| 3 | AMGN |
Amgen Inc
This page
|
7,005 | $2,536,650 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
16,440 | $2,077,029 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,583 | $1,102,915 | |
| 6 | ABBV |
AbbVie Inc.
|
3,156 | $794,175 | |
| 7 | NVO |
Novo Nordisk A S
|
10,744 | $515,067 | |
| 8 | NVS |
Novartis AG
|
2,210 | $346,351 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,536,650 | 7,005 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,460,135 | 6,992 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,093,802 | 6,397 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,701,383 | 6,029 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,314,241 | 4,707 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,615,075 | 5,184 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,078,788 | 4,139 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $920,553 | 2,857 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $415,558 | 1,330 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $376,724 | 1,325 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $380,474 | 1,321 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $514,137 | 1,913 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $428,498 | 1,930 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $350,537 | 1,450 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $355,877 | 1,355 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $281,975 | 1,251 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $302,665 | 1,244 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $289,216 | 1,196 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $290,886 | 1,293 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $325,779 | 1,532 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $439,237 | 1,802 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $417,503 | 1,678 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $331,774 | 1,443 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $362,940 | 1,428 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $336,808 | 1,428 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $239,221 | 1,180 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||